Fundraising Fox
/Companies
Sign in

ImmuneSensor Therapeutics

Dallas, US · Founded 2019 · Delaware corporation

Find your way into ImmuneSensor Therapeutics

Sign up to see every warm intro you have to ImmuneSensor Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the ImmuneSensor Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

ImmuneSensor Therapeutics is a clinical-stage biotechnology company developing orally available small molecule cGAS inhibitors that target the cGAS-STING innate immune pathway to treat inflammatory and autoimmune diseases. Founded on research from UT Southwestern Medical Center, it advances a pipeline of drug candidates for immune-related conditions.

BiotechDeep TechHealthtech

Founders & leadership

ImmuneSensor Therapeutics was founded in 2019 by Zhijian "James" Chen and Jet Li.

Z"
Zhijian "James" Chen
JLJet Li
Jet LiBoard Chairman and Co-Founder
TWThomas W. Dubensky, Jr., Ph.D.
Thomas W. Dubensky, Jr., Ph.D.President and Chief Executive Officer
L'
Lijun 'Josh' Sun, Ph.D.VP, Research & Development
TMTeresa Mooneyham
Teresa MooneyhamVP, Clinical Operations & Head of Project Management
BL
Betty LawrenceVP, Toxicology and Regulatory
QL
Qingsong LiNamed on SEC filing
ZH
Zhi HongNamed on SEC filing
EW
Ernest WongNamed on SEC filing
NZ
Ning ZhangNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$10M disclosed across 1 round · 2022

▶$10MraisedDec 2022 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Qingsong LiExecutive Officer, Director
  • Zhi HongDirector
  • Ernest WongExecutive Officer, Director
  • Ning ZhangDirector
Offering amount
$20M
Amount sold
$10M
First sale
Nov 2022
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

OupOxford University Press (OUP) provides dictionary data, language datasets, and lexical content in over 60 languages to power digital literacy tools, educational software, gaming platforms, and media experiences. The company works across reading apps, word games, quiz shows, and broadcast media to expand access to language learning and comprehension.

Companies working in the same space as ImmuneSensor Therapeutics.

In the news

ImmuneSensor Therapeutics Appoints Veteran Biopharma Executive, Thomas W. Dubensky, Jr., Ph.D., as Chief Executive Officerfinance.yahoo.com · May 2024

Frequently asked questions

What does ImmuneSensor Therapeutics do?
ImmuneSensor Therapeutics is a clinical-stage biotechnology company developing orally available small molecule cGAS inhibitors that target the cGAS-STING innate immune pathway to treat inflammatory and autoimmune diseases. Founded on research from UT Southwestern Medical Center, it advances a pipeline of drug candidates for immune-related conditions.
Who founded ImmuneSensor Therapeutics?
ImmuneSensor Therapeutics was founded by Zhijian "James" Chen, Jet Li in 2019.
How much funding has ImmuneSensor Therapeutics raised?
ImmuneSensor Therapeutics has disclosed $10M raised across 1 round.
Where is ImmuneSensor Therapeutics headquartered?
ImmuneSensor Therapeutics is headquartered in Dallas, US.